Global HSV Antibody Market Growth (Status and Outlook) 2022-2028
- LP 4879962
- 87 Pages
- March 2022
- Pharmaceuticals
The United States HSV Antibody market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global HSV Antibody market, reaching US$ million by the year 2028. As for the Europe HSV Antibody landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main HSV Antibody players cover Santa Cruz Biotechnology, Bethyl, Origene, and United States Biological, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of HSV Antibody market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Polyclonal
Monoclonal
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Immunocytochemistry
Western Blot
Immunofluorescence
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Santa Cruz Biotechnology
Bethyl
Origene
United States Biological
LSBio
EXBIO
ProSci
Novus Biologicals
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global HSV Antibody Market Size 2017-2028
2.1.2 HSV Antibody Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 HSV Antibody Segment by Type
2.2.1 Polyclonal
2.2.2 Monoclonal
2.3 HSV Antibody Market Size by Type
2.3.1 HSV Antibody Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global HSV Antibody Market Size Market Share by Type (2017-2022)
2.4 HSV Antibody Segment by Application
2.4.1 Immunocytochemistry
2.4.2 Western Blot
2.4.3 Immunofluorescence
2.4.4 Others
2.5 HSV Antibody Market Size by Application
2.5.1 HSV Antibody Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global HSV Antibody Market Size Market Share by Application (2017-2022)
3 HSV Antibody Market Size by Player
3.1 HSV Antibody Market Size Market Share by Players
3.1.1 Global HSV Antibody Revenue by Players (2020-2022)
3.1.2 Global HSV Antibody Revenue Market Share by Players (2020-2022)
3.2 Global HSV Antibody Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HSV Antibody by Regions
4.1 HSV Antibody Market Size by Regions (2017-2022)
4.2 Americas HSV Antibody Market Size Growth (2017-2022)
4.3 APAC HSV Antibody Market Size Growth (2017-2022)
4.4 Europe HSV Antibody Market Size Growth (2017-2022)
4.5 Middle East & Africa HSV Antibody Market Size Growth (2017-2022)
5 Americas
5.1 Americas HSV Antibody Market Size by Country (2017-2022)
5.2 Americas HSV Antibody Market Size by Type (2017-2022)
5.3 Americas HSV Antibody Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC HSV Antibody Market Size by Region (2017-2022)
6.2 APAC HSV Antibody Market Size by Type (2017-2022)
6.3 APAC HSV Antibody Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe HSV Antibody by Country (2017-2022)
7.2 Europe HSV Antibody Market Size by Type (2017-2022)
7.3 Europe HSV Antibody Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa HSV Antibody by Region (2017-2022)
8.2 Middle East & Africa HSV Antibody Market Size by Type (2017-2022)
8.3 Middle East & Africa HSV Antibody Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global HSV Antibody Market Forecast
10.1 Global HSV Antibody Forecast by Regions (2023-2028)
10.1.1 Global HSV Antibody Forecast by Regions (2023-2028)
10.1.2 Americas HSV Antibody Forecast
10.1.3 APAC HSV Antibody Forecast
10.1.4 Europe HSV Antibody Forecast
10.1.5 Middle East & Africa HSV Antibody Forecast
10.2 Americas HSV Antibody Forecast by Country (2023-2028)
10.2.1 United States HSV Antibody Market Forecast
10.2.2 Canada HSV Antibody Market Forecast
10.2.3 Mexico HSV Antibody Market Forecast
10.2.4 Brazil HSV Antibody Market Forecast
10.3 APAC HSV Antibody Forecast by Region (2023-2028)
10.3.1 China HSV Antibody Market Forecast
10.3.2 Japan HSV Antibody Market Forecast
10.3.3 Korea HSV Antibody Market Forecast
10.3.4 Southeast Asia HSV Antibody Market Forecast
10.3.5 India HSV Antibody Market Forecast
10.3.6 Australia HSV Antibody Market Forecast
10.4 Europe HSV Antibody Forecast by Country (2023-2028)
10.4.1 Germany HSV Antibody Market Forecast
10.4.2 France HSV Antibody Market Forecast
10.4.3 UK HSV Antibody Market Forecast
10.4.4 Italy HSV Antibody Market Forecast
10.4.5 Russia HSV Antibody Market Forecast
10.5 Middle East & Africa HSV Antibody Forecast by Region (2023-2028)
10.5.1 Egypt HSV Antibody Market Forecast
10.5.2 South Africa HSV Antibody Market Forecast
10.5.3 Israel HSV Antibody Market Forecast
10.5.4 Turkey HSV Antibody Market Forecast
10.5.5 GCC Countries HSV Antibody Market Forecast
10.6 Global HSV Antibody Forecast by Type (2023-2028)
10.7 Global HSV Antibody Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Santa Cruz Biotechnology
11.1.1 Santa Cruz Biotechnology Company Information
11.1.2 Santa Cruz Biotechnology HSV Antibody Product Offered
11.1.3 Santa Cruz Biotechnology HSV Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Santa Cruz Biotechnology Main Business Overview
11.1.5 Santa Cruz Biotechnology Latest Developments
11.2 Bethyl
11.2.1 Bethyl Company Information
11.2.2 Bethyl HSV Antibody Product Offered
11.2.3 Bethyl HSV Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Bethyl Main Business Overview
11.2.5 Bethyl Latest Developments
11.3 Origene
11.3.1 Origene Company Information
11.3.2 Origene HSV Antibody Product Offered
11.3.3 Origene HSV Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Origene Main Business Overview
11.3.5 Origene Latest Developments
11.4 United States Biological
11.4.1 United States Biological Company Information
11.4.2 United States Biological HSV Antibody Product Offered
11.4.3 United States Biological HSV Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 United States Biological Main Business Overview
11.4.5 United States Biological Latest Developments
11.5 LSBio
11.5.1 LSBio Company Information
11.5.2 LSBio HSV Antibody Product Offered
11.5.3 LSBio HSV Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 LSBio Main Business Overview
11.5.5 LSBio Latest Developments
11.6 EXBIO
11.6.1 EXBIO Company Information
11.6.2 EXBIO HSV Antibody Product Offered
11.6.3 EXBIO HSV Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 EXBIO Main Business Overview
11.6.5 EXBIO Latest Developments
11.7 ProSci
11.7.1 ProSci Company Information
11.7.2 ProSci HSV Antibody Product Offered
11.7.3 ProSci HSV Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 ProSci Main Business Overview
11.7.5 ProSci Latest Developments
11.8 Novus Biologicals
11.8.1 Novus Biologicals Company Information
11.8.2 Novus Biologicals HSV Antibody Product Offered
11.8.3 Novus Biologicals HSV Antibody Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Novus Biologicals Main Business Overview
11.8.5 Novus Biologicals Latest Developments
12 Research Findings and Conclusion
Table 1. HSV Antibody Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Polyclonal
Table 3. Major Players of Monoclonal
Table 4. HSV Antibody Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global HSV Antibody Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global HSV Antibody Market Size Market Share by Type (2017-2022)
Table 7. HSV Antibody Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global HSV Antibody Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global HSV Antibody Market Size Market Share by Application (2017-2022)
Table 10. Global HSV Antibody Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global HSV Antibody Revenue Market Share by Player (2020-2022)
Table 12. HSV Antibody Key Players Head office and Products Offered
Table 13. HSV Antibody Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global HSV Antibody Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global HSV Antibody Market Size Market Share by Regions (2017-2022)
Table 18. Americas HSV Antibody Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas HSV Antibody Market Size Market Share by Country (2017-2022)
Table 20. Americas HSV Antibody Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas HSV Antibody Market Size Market Share by Type (2017-2022)
Table 22. Americas HSV Antibody Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas HSV Antibody Market Size Market Share by Application (2017-2022)
Table 24. APAC HSV Antibody Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC HSV Antibody Market Size Market Share by Region (2017-2022)
Table 26. APAC HSV Antibody Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC HSV Antibody Market Size Market Share by Type (2017-2022)
Table 28. APAC HSV Antibody Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC HSV Antibody Market Size Market Share by Application (2017-2022)
Table 30. Europe HSV Antibody Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe HSV Antibody Market Size Market Share by Country (2017-2022)
Table 32. Europe HSV Antibody Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe HSV Antibody Market Size Market Share by Type (2017-2022)
Table 34. Europe HSV Antibody Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe HSV Antibody Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa HSV Antibody Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa HSV Antibody Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa HSV Antibody Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa HSV Antibody Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa HSV Antibody Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa HSV Antibody Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of HSV Antibody
Table 43. Key Market Challenges & Risks of HSV Antibody
Table 44. Key Industry Trends of HSV Antibody
Table 45. Global HSV Antibody Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global HSV Antibody Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global HSV Antibody Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global HSV Antibody Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global HSV Antibody Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global HSV Antibody Market Size Market Share Forecast by Application (2023-2028)
Table 51. Santa Cruz Biotechnology Details, Company Type, HSV Antibody Area Served and Its Competitors
Table 52. Santa Cruz Biotechnology HSV Antibody Product Offered
Table 53. Santa Cruz Biotechnology HSV Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Santa Cruz Biotechnology Main Business
Table 55. Santa Cruz Biotechnology Latest Developments
Table 56. Bethyl Details, Company Type, HSV Antibody Area Served and Its Competitors
Table 57. Bethyl HSV Antibody Product Offered
Table 58. Bethyl Main Business
Table 59. Bethyl HSV Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Bethyl Latest Developments
Table 61. Origene Details, Company Type, HSV Antibody Area Served and Its Competitors
Table 62. Origene HSV Antibody Product Offered
Table 63. Origene Main Business
Table 64. Origene HSV Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Origene Latest Developments
Table 66. United States Biological Details, Company Type, HSV Antibody Area Served and Its Competitors
Table 67. United States Biological HSV Antibody Product Offered
Table 68. United States Biological Main Business
Table 69. United States Biological HSV Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. United States Biological Latest Developments
Table 71. LSBio Details, Company Type, HSV Antibody Area Served and Its Competitors
Table 72. LSBio HSV Antibody Product Offered
Table 73. LSBio Main Business
Table 74. LSBio HSV Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. LSBio Latest Developments
Table 76. EXBIO Details, Company Type, HSV Antibody Area Served and Its Competitors
Table 77. EXBIO HSV Antibody Product Offered
Table 78. EXBIO Main Business
Table 79. EXBIO HSV Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. EXBIO Latest Developments
Table 81. ProSci Details, Company Type, HSV Antibody Area Served and Its Competitors
Table 82. ProSci HSV Antibody Product Offered
Table 83. ProSci Main Business
Table 84. ProSci HSV Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. ProSci Latest Developments
Table 86. Novus Biologicals Details, Company Type, HSV Antibody Area Served and Its Competitors
Table 87. Novus Biologicals HSV Antibody Product Offered
Table 88. Novus Biologicals Main Business
Table 89. Novus Biologicals HSV Antibody Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Novus Biologicals Latest Developments
List of Figures
Figure 1. HSV Antibody Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global HSV Antibody Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global HSV Antibody Market Size Market Share by Type in 2021
Figure 7. HSV Antibody in Immunocytochemistry
Figure 8. Global HSV Antibody Market: Immunocytochemistry (2017-2022) & ($ Millions)
Figure 9. HSV Antibody in Western Blot
Figure 10. Global HSV Antibody Market: Western Blot (2017-2022) & ($ Millions)
Figure 11. HSV Antibody in Immunofluorescence
Figure 12. Global HSV Antibody Market: Immunofluorescence (2017-2022) & ($ Millions)
Figure 13. HSV Antibody in Others
Figure 14. Global HSV Antibody Market: Others (2017-2022) & ($ Millions)
Figure 15. Global HSV Antibody Market Size Market Share by Application in 2021
Figure 16. Global HSV Antibody Revenue Market Share by Player in 2021
Figure 17. Global HSV Antibody Market Size Market Share by Regions (2017-2022)
Figure 18. Americas HSV Antibody Market Size 2017-2022 ($ Millions)
Figure 19. APAC HSV Antibody Market Size 2017-2022 ($ Millions)
Figure 20. Europe HSV Antibody Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa HSV Antibody Market Size 2017-2022 ($ Millions)
Figure 22. Americas HSV Antibody Value Market Share by Country in 2021
Figure 23. Americas HSV Antibody Consumption Market Share by Type in 2021
Figure 24. Americas HSV Antibody Market Size Market Share by Application in 2021
Figure 25. United States HSV Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada HSV Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico HSV Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil HSV Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC HSV Antibody Market Size Market Share by Region in 2021
Figure 30. APAC HSV Antibody Market Size Market Share by Application in 2021
Figure 31. China HSV Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan HSV Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea HSV Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia HSV Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 35. India HSV Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia HSV Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe HSV Antibody Market Size Market Share by Country in 2021
Figure 38. Europe HSV Antibody Market Size Market Share by Type in 2021
Figure 39. Europe HSV Antibody Market Size Market Share by Application in 2021
Figure 40. Germany HSV Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 41. France HSV Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK HSV Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy HSV Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia HSV Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa HSV Antibody Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa HSV Antibody Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa HSV Antibody Market Size Market Share by Application in 2021
Figure 48. Egypt HSV Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa HSV Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel HSV Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey HSV Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country HSV Antibody Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas HSV Antibody Market Size 2023-2028 ($ Millions)
Figure 54. APAC HSV Antibody Market Size 2023-2028 ($ Millions)
Figure 55. Europe HSV Antibody Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa HSV Antibody Market Size 2023-2028 ($ Millions)
Figure 57. United States HSV Antibody Market Size 2023-2028 ($ Millions)
Figure 58. Canada HSV Antibody Market Size 2023-2028 ($ Millions)
Figure 59. Mexico HSV Antibody Market Size 2023-2028 ($ Millions)
Figure 60. Brazil HSV Antibody Market Size 2023-2028 ($ Millions)
Figure 61. China HSV Antibody Market Size 2023-2028 ($ Millions)
Figure 62. Japan HSV Antibody Market Size 2023-2028 ($ Millions)
Figure 63. Korea HSV Antibody Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia HSV Antibody Market Size 2023-2028 ($ Millions)
Figure 65. India HSV Antibody Market Size 2023-2028 ($ Millions)
Figure 66. Australia HSV Antibody Market Size 2023-2028 ($ Millions)
Figure 67. Germany HSV Antibody Market Size 2023-2028 ($ Millions)
Figure 68. France HSV Antibody Market Size 2023-2028 ($ Millions)
Figure 69. UK HSV Antibody Market Size 2023-2028 ($ Millions)
Figure 70. Italy HSV Antibody Market Size 2023-2028 ($ Millions)
Figure 71. Russia HSV Antibody Market Size 2023-2028 ($ Millions)
Figure 72. Spain HSV Antibody Market Size 2023-2028 ($ Millions)
Figure 73. Egypt HSV Antibody Market Size 2023-2028 ($ Millions)
Figure 74. South Africa HSV Antibody Market Size 2023-2028 ($ Millions)
Figure 75. Israel HSV Antibody Market Size 2023-2028 ($ Millions)
Figure 76. Turkey HSV Antibody Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries HSV Antibody Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
